PHE News

Philipson in Forbes: Is Disneyland the Future of Personalized Medicine?

PHE's Tomas Philipson suggests that the pricing system used by Disneyland and other amusement parks is a concept applicable to personalized medicine.

READ MORE

Shafrin Blog Named One of the Top 100 Economics Blogs of 2016

PHE senior research economist Jason Shafrin's blog, "Healthcare Economist," has been named as one of the top 100 economics blogs of 2016 by Intelligent Economist.

READ MORE

PHE's Anupam Jena Named One of the 60 Most Powerful People in Healthcare for 2016

Precision Health Economics is proud to announce that scientific advisor Anupam Jena, MD has been named by Becker's Hospital Review as one of the 60 most powerful people in healthcare in 2016, joining other influential leaders such as Robert Califf, Frances Collins, David Feinberg, Bill & Melinda Gates, Barack Obama, and Donald Trump.

READ MORE

Shafrin Interviewed in The Journal of Healthcare Contracting

PHE's Jason Shafrin discusses the need for and mission of the Innovation and Value Initiative, as well as the keys to its success in the latest edition of The Journal of Healthcare Contracting.

READ MORE

PHE's Linthicum and Shafrin Discuss Value Assessment in GEN News

Mark Linthicum and Jason Shafrin discuss the science of value assessment and the mission of the Innovation and Value Initiative in the latest edition of Genetic Engineering and Biotechnology News.

READ MORE
 
  • Academic Insights at

    the Speed of Business

     
  • Intellectual Integrity

    Led by professors at elite research universities, we bring intellectual integrity, academic rigor, and a creative approach to the most challenging problems in heath care.

     
  • Real World Impact

    PHE recommendations have defined and changed national and international payment policies.

     
  • Unparalleled Influence

    We frequently appear in top-tier publications and media outlets-- our work reaches top decision makers and influences outcomes.

     
  • Evidence Generation and

    Commercial Excellence

    As part of Precision for Value, our academic approach to research can be linked with a tailored, commercial approach that demonstrates the value of innovative medications.

     
  • Academic Insights at

    the Speed of Business